Roberto Costillas Perez: New Insights on Assisted Hatching Efficacy in IVF
Roberto Costillas Perez, Founder and CEO at Fertypharm, shared a post on LinkedIn about a paper by A. Kusamoto et al. published on Scientific Reports:
“New massive study on Assisted Hatching (AH) in IVF! Does it really improve clinical outcomes?
A retrospective analysis of 1,678,872 single embryo transfers (SET), based on the Japan Assisted Reproductive Technology Registry (2010-2019), sheds light on the true efficacy of AH. This procedure, applied in 55% of cycles, was evaluated in both crude and propensity score-adjusted analyses (considering maternal age, embryo type, stage, ART indication, and endometrial preparation).
Key Results
In crude data, AH showed higher rates of clinical pregnancy (32.8% vs 28%) and live birth (23.2% vs 20.3%). However, after statistical adjustments, the differences slightly reversed:
- Clinical pregnancy: 31.3% with AH vs 29.6% without (difference of -1.64%).
- Live birth: 22.4% vs 21.2% (difference of -1.20%).
These findings suggest the initial apparent benefit may be due to confounding factors.
Subgroup Analysis
The only clear benefit was seen in women under 35 years with thawed cryopreserved blastocyst transfer, where the live birth rate reached 37.7% with AH vs 36.6%. In contrast, reductions were noted in most subgroups, along with elevated risks:
- ↑ Spontaneous abortion (+0.82%).
- ↑ Multiple pregnancies (+0.23%).
- ↑ Placenta accreta spectrum (+0.12%).
Clinical Implications
These results question the routine use of AH, as it worsens outcomes in most cases, especially in fresh cycles and older women. It is recommended to reserve it selectively for young patients with frozen blastocysts.”
Title: Effect of assisted hatching on pregnancy outcomes following 1,678,872 single embryo transfers based on the Japan Assisted Reproductive Technology Registry
Authors: A. Kusamoto, M. Harada, T. Kawahara, H. Koike, C. Kunitomi, Y. Fukui, Y. Sanada, N. Takahashi, M. Matsuo, T. Makabe, Y. Urata,G. Izumi, N. Ooi, O. Hiraike, Y. Osuga, Y. Hirota
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 9, 2026, 11:20Lucile Ferreux: What History Teaches Us About the Place of Human Health
-
Jan 9, 2026, 11:02January Insights Reflecting on 2025’s Top Fertility Research – RBMO
-
Jan 8, 2026, 19:00Michaela Hofbauer: 2025 Marked a Turning Point for Women’s Health
-
Jan 8, 2026, 18:55Margot Lherbet: Insights on Surrogacy Perspectives from French Experts
-
Jan 8, 2026, 18:52Meghan White: Exploring Endometriosis Impact on Male Partners
-
Jan 8, 2026, 18:47Transforming Endometriosis Diagnosis Through Symptom Tracking – Womb WatchAI
-
Jan 8, 2026, 18:43Anushree Nandan: Cutting-Edge Research on PRC1 Proteins and Endometriosis
-
Jan 8, 2026, 17:46Swapna Nhavi: Revolutionizing Ovarian Tissue Preservation
-
Jan 8, 2026, 12:24Sun-Wei Guo Joins Foraviset’s Scientific Advisory Board – Foraviset